https://thehill.com/changing-americ...08-faucis-boss-praises-trump-for-breathtaking “The Operation Warp Speed, for which I give a great deal of credit to secretary [Alex] Azar, was an effort that many of us were not initially convinced was going to be necessary and it was thought about as a Manhattan Project,” Collins told Axios referring to the U.S. program that developed the first nuclear weapons during World War II. “Those words were used sometimes to describe what needed to happen in order to get all parts of the government together in an unprecedented way to test up to six vaccines in rigorous trials, and to do this at-risk manufacturing so that if any of those trials happen to work, you would already have doses ready to go into arms,” he said, adding “that would not be the way things are traditionally done.”
You changed the premise to get your snark in Correct fact: All vaccines given to date were acquired by Trump (administration)
@gwb-trading This GOA report destroys your argument. You should read the entire report. https://www.gao.gov/assets/720/712371.pdf Operation Warp Speed (OWS)—a partnership between the Departments of Health and Human Services (HHS) and Defense (DOD)—aimed to help accelerate the development of a COVID-19 vaccine. GAO found that OWS and vaccine companies adopted several strategies to accelerate vaccine development and mitigate risk. For example, OWS selected vaccine candidates that use different mechanisms to stimulate an immune response (i.e., platform technologies; see figure). Vaccine companies also took steps, such as starting large-scale manufacturing during clinical trials and combining clinical trial phases or running them concurrently. Clinical trials gather data on safety and efficacy, with more participants in each successive phase (e.g., phase 3 has more participants than phase 2). As of January 30, 2021, five of the six OWS vaccine candidates have entered phase 3 clinical trials, two of which—Moderna’s and Pfizer/BioNTech’s vaccines—have received an emergency use authorization (EUA) from the Food and Drug Administration (FDA). For vaccines that received EUA, additional data on vaccine effectiveness will be generated from further follow-up of participants in clinical trials already underway before the EUA was issued. For example, one vaccine company told GAO that HHS’s Biomedical Advanced Research and Development Authority helped them identify an additional manufacturing partner to increase production. Additionally, the U.S. Army Corps of Engineers is overseeing construction projects to expand capacity at vaccine manufacturing facilities.
@gwb-trading https://www.gao.gov/assets/720/712371.pdf Vaccine companies and DOD and HHS officials told GAO they have undertaken several efforts to address possible manufacturing disruptions and mitigate supply chain challenges. These efforts include federal assistance to (1) expedite procurement and delivery of critical manufacturing equipment, (2) develop a list of critical supplies that are common across the six OWS vaccine candidates, and (3) expedite the delivery of necessary equipment and goods coming into the United States. Additionally, DOD and HHS officials said that as of December 2020 they had placed prioritized ratings on 18 supply contracts for vaccine companies under the Defense Production Act, which allows federal agencies with delegated authority to require contractors to prioritize those contracts for supplies needed for vaccine production. Gaps in the available workforce: Hiring and training personnel with the specialized skills needed to run vaccine manufacturing processes can be challenging. OWS officials stated that they have worked with the Department of State to expedite visa approval for key technical personnel, including technicians and engineers to assist with installing, testing, and certifying critical equipment manufactured overseas. OWS officials also stated that they requested that 16 DOD personnel be detailed to serve as quality control staff at two vaccine manufacturing sites until the organizations can hire the required personnel.